Total Pharmacy® October 2024

Jon Minkin, enterprise account executive at NimbleRx, shared how his company can help independent pharmacies unlock revenue opportunities.

Erin Albert, vice president of pharmacy relations and chief privacy officer at Mark Cuban Cost Plus Drug Company, PBC, discussed drug pricing and what her company is doing to revolutionize transparency.

Emily Endres, BSPS, vice president of pharmacy at PQS by Innovaccer, provides insights into the industry’s next phase.

Adherence interventions and comprehensive reviews can reduce health care costs, boost revenue, and improve patient outcomes.

Medication therapy management can change the trajectory of patient health outcomes. Here is how pharmacists can ensure adherence and compensation.

A roundtable session discussed the real-world implications of applying DIR fees at the point of sale rather than through retroactive clawback.

Following the Federal Trade Commission’s interim report on PBMs, legislators are galvanized to make change happen.

Independent pharmacists, health care providers, community leaders, and law enforcement must all work together to address the fentanyl epidemic.